COMMUNIQUÉS West-GlobeNewswire

ChromaDex Furthers TRU NIAGEN® Global Expansion in Canada with WELL Health Technologies
24/04/2019
Distribution agreement for Tru Niagen (nicotinamide riboside) in Vancouver area provides access to high-end pharmacies and clinics LOS ANGELES, April 24, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced [...]
Integra LifeSciences Reports First Quarter 2019 Financial Results
24/04/2019
Reported revenues amounted to $359.7 million; organic revenues increased 3.1% GAAP and adjusted earnings per diluted share were $0.38 and $0.65, respectively The Company reaffirms reported and organic revenue guidance [...]
Amarin To Report First Quarter 2019 Results and Host Conference Call On May 1, 2019
24/04/2019
BEDMINSTER, N.J. and DUBLIN, Ireland, April 24, 2019 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on improving cardiovascular health, today announced that it will host a [...]
Professor Paul Fitzgerald joins Nexstim's Scientific Advisory Board
24/04/2019
Press release, Helsinki, 24 April 2019 at 9.30 am (EET) Professor Paul Fitzgerald joins Nexstim's Scientific Advisory Board Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and [...]
CellaVision AB presents the first quarter for 2019 on May 7 at 11:00 CET
24/04/2019
The information was submitted to the public on April 24, 2018 at 8:20 CET CellaVision AB (publ) will publish the interim report for the first quarter on May 7, 2019 at 8:20 CET. The report will be available at www. [...]
Interim report for the first 3 months of 2019
24/04/2019
Please read the full announcement in the attached PDF Attachment 2019_07_Q12019_CompanyAnnouncement_EN_FINAL
Oxurion NV announces full enrollment in its Phase 1 trial evaluating the safety of its plasma kallikrein inhibitor THR-149 for treatment of DME, ahead of schedule
24/04/2019
Leuven, Belgium, 24 April 2019 - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing innovative treatments to preserve vision in patients with diabetic eye disease, announces today that it has [...]
Novartis starts 2019 with strong sales and double digit core[1] operating income growth, Mayzent launch and Alcon spin-off; profit guidance upgraded
24/04/2019
Transformation to focused medicines company continued with the spin-off of Alcon; commentary below is on continuing operations[2] Continuing operations net sales up 7% (cc[1], +2% USD) driven by Innovative Medicines: [...]
Novartis entame 2019 avec une forte croissance des ventes et une hausse à deux chiffres du résultat opérationnel core[1], le lancement de Mayzent et le spin-off d'Alcon; profit annuel revu à la hausse
24/04/2019
La transformation en une société axée sur les médicaments a continué avec le spin-off d'Alcon; les commentaires ci-après ne concernent que les activités poursuivies[2] Chiffre d'affaires net des activités poursuivies en [...]
MDxHealth (R): MDxHealth provides Q1 2019 business update
24/04/2019
NEWS RELEASE REGULATED INFORMATION IRVINE, CA, and HERSTAL, BELGIUM - April 24, 2019 - MDxHealth SA (Euronext: MDXH.BR), a commercial-stage innovative molecular diagnostics company, today provided a business update for [...]
MDxHealth (R) : MDxHealth publie son rapport d'activité du T1 2019
24/04/2019
COMMUNIQUÉ DE PRESSE INFORMATIONS RÉGLEMENTÉES IRVINE, CA, et HERSTAL, Belgique - le 24 avril 2019 - MDxHealth SA (Euronext : MDXH.BR), une société spécialisée dans le diagnostic moléculaire à un stade commercial, a [...]
Number of shares and voting rights of Innate Pharma as at April 18, 2019
24/04/2019
NUMBER OF SHARES AND VOTING RIGHTS OF INNATE PHARMA AS AT APRIL 18, 2019 Marseille, France, April 24, 2018, 7:00 AM CET Pursuant to the article L. 233-8 II of the French « Code de Commerce » and the article 223-16 of [...]
Nouveau nombre d’actions et de droits de vote d’Innate Pharma au 18 avril 2019
24/04/2019
NOUVEAU NOMBRE D’ACTIONS ET DE DROITS DE VOTE D’INNATE PHARMA AU 18 AVRIL 2019 Marseille, le 24 avril 2019, 7h00 CET Conformément aux articles L. 233-8 II du Code de Commerce et 223-16 du règlement général de l’Autorité [...]
Pixium Vision and research partners to report clinical progress with the PRIMA bionic vision system during ARVO 2019 World Conference
24/04/2019
Paris, April 24 th , 2019 – 7:00 CET - Pixium Vision (FR0011950641 - PIX), a bioelectronics company developing innovative bionic vision systems to enable patients who have lost their sight to lead more independent lives [...]
Pixium Vision et ses partenaires de recherche présenteront les progrès cliniques du système vision bionique PRIMA lors du congrès mondial de l’ARVO 2019
24/04/2019
Paris, 24 avril 2019 – 7:00 CET - Pixium Vision (FR0011950641 - PIX), société bioélectronique qui développe des systèmes de vision bionique innovants pour permettre aux patients ayant perdu la vue de vivre de façon plus [...]
China FDA Approval for Oscar 2 Blood Pressure Monitor with CardieX’s "SphygmoCor® Inside" Technology
24/04/2019
SYDNEY, Australia, April 23, 2019 (GLOBE NEWSWIRE) -- CardieX Limited (Australian Stock Exchange listed: CDX) announces approval by the Chinese Food and Drug Administration (CFDA) of the Oscar 2 with “ SphygmoCor® [...]
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Glioblastoma
24/04/2019
LA JOLLA, Calif., April 23, 2019 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875), [...]
Psychemedics Announces First Quarter Results and Declares 91st Consecutive Quarterly Dividend
23/04/2019
ACTON, Mass., April 23, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced first quarter financial results for the period ended March 31, 2019. The Company also announced a quarterly dividend [...]
Harvard Bioscience Schedules First Quarter 2019 Conference Call for May 2 at 4:30 PM ET
23/04/2019
HOLLISTON, Mass., April 23, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results [...]

Pages